$AEON Biopharma(AEON)$ Setting

$AEON Biopharma(AEON)$ Setting up for another big move.

Strong volume came in, the stock pushed as high as $0.33, and now the key battle is the $0.30–$0.33 resistance zone. If buyers reclaim that area with volume, momentum could accelerate quickly.

Recent analyst coverage also remains bullish on the longer-term ABP-450 opportunity.

Watching $0.24 support, then $0.30 reclaim, then $0.33 breakout closely.

$Tonix Pharmaceuticals(TNXP)$ $Moderna, Inc.(MRNA)$ $SELLAS Life Sciences Group Inc.(SLS)$ $ImmunityBio, Inc.(IBRX)$

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":601725391504896,"tweetId":"601725391504896","gmtCreate":1787853826000,"gmtModify":1787923506011,"author":{"id":10000000000011394,"idStr":"10000000000011394","authorId":10000000000011394,"authorIdStr":"10000000000011394","name":"Joanne Elinor","avatar":"https://static.tigerbbs.com/6f7166a326215342170a47ea96e7e877","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><a href=\"https://ttm.financial/S/AEON\">$AEON Biopharma(AEON)$&nbsp;</a>Setting up for another big move.\nStrong volume came in, the stock pushed as high as $0.33, and now the key battle is the $0.30–$0.33 resistance zone. If buyers reclaim that area with volume, momentum could accelerate quickly.\nRecent analyst coverage also remains bullish on the longer-term ABP-450 opportunity.\nWatching $0.24 support, then $0.30 reclaim, then $0.33 breakout closely.\n<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a> <a href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$&nbsp;</a> <a href=\"https://ttm.financial/S/SLS\">$SELLAS Life Sciences Group Inc.(SLS)$&nbsp;</a> <a href=\"https://ttm.financial/S/IBRX\">$ImmunityBio, Inc.(IBRX)$&nbsp;</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/AEON\">$AEON Biopharma(AEON)$&nbsp;</a>Setting up for another big move.\nStrong volume came in, the stock pushed as high as $0.33, and now the key battle is the $0.30–$0.33 resistance zone. If buyers reclaim that area with volume, momentum could accelerate quickly.\nRecent analyst coverage also remains bullish on the longer-term ABP-450 opportunity.\nWatching $0.24 support, then $0.30 reclaim, then $0.33 breakout closely.\n<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a> <a href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$&nbsp;</a> <a href=\"https://ttm.financial/S/SLS\">$SELLAS Life Sciences Group Inc.(SLS)$&nbsp;</a> <a href=\"https://ttm.financial/S/IBRX\">$ImmunityBio, Inc.(IBRX)$&nbsp;</a></body></html>","text":"$AEON Biopharma(AEON)$ Setting up for another big move. Strong volume came in, the stock pushed as high as $0.33, and now the key battle is the $0.30–$0.33 resistance zone. If buyers reclaim that area with volume, momentum could accelerate quickly. Recent analyst coverage also remains bullish on the longer-term ABP-450 opportunity. Watching $0.24 support, then $0.30 reclaim, then $0.33 breakout closely. $Tonix Pharmaceuticals(TNXP)$ $Moderna, Inc.(MRNA)$ $SELLAS Life Sciences Group Inc.(SLS)$ $ImmunityBio, Inc.(IBRX)$","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/601725391504896","repostId":0,"isVote":1,"tweetType":1,"viewCount":207,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["SLS","MRNA","AEON","IBRX","TNXP"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":452,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/601725391504896"}